GUJTHEM.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Drug Manufacturers - Specialty & Generic

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
GUJTHEM.BOGujarat Themis Biosyn Limited	$428.45	+1.20%	$46.7B	—
AARTIDRUGS.BOAarti Drugs Limited	$426.85	-0.32%	$39.0B	—
AARTIDRUGS.NSAarti Drugs Limited	$426.35	-0.50%	$38.9B	—
DCAL.BODishman Carbogen Amcis Limited	$162.85	-2.78%	$25.6B	—
DCAL.NSDishman Carbogen Amcis Limited	$163.16	-2.45%	$25.6B	—
INDRAMEDCO.BOIndraprastha Medical Corporation Limited	$354.90	+0.18%	$32.5B	—
INDRAMEDCO.NSIndraprastha Medical Corporation Limited	$354.55	-0.13%	$32.5B	—

Source: Financial Modeling Prep · peers by sector/industry

Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited functions as a pharmaceutical company, specializing in the production of various drugs. Its key pharmaceutical offerings include Rifamycin and Lovastatin. The company was incorporated on December 11, 1981, and maintains its headquarters in Mumbai, India.

www.gtbl.in

Employees: 159
IPO / List date: Jan 2, 2002
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds GUJTHEM.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in GUJTHEM.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded GUJTHEM.BO yet.